Patients with left main coronary artery disease who present with ACS fare just as well when treated with PCI as they do with CABG surgery, according to results of a new study. While ACS patients had ...

Dual antiplatelet therapy (DAPT) consisting of aspirin plus a P2Y 12 inhibitor has been the standard of care to prevent thrombotic events in patients with acute coronary syndrome (ACS) undergoing ...

BARCELONA, SPAIN — Overall clinical risk at 1 year went up significantly in patients receiving PCI for acute coronary syndrome (ACS) after the European guidelines switched to recommending ticagrelor ...

Please provide your email address to receive an email when new articles are posted on . In a real-world cohort of Medicare beneficiaries with ACS and multivessel CAD, CABG conferred lower odds of ...

Despite getting even more new data this April supporting the practice of using ticagrelor monotherapy as soon as 1 month after PCI for ACS, many cardiologists seem wary about dropping aspirin so ...

Please provide your email address to receive an email when new articles are posted on . The 2020 ESC guidelines identified patients undergoing PCI at low-, moderate- and high-risk for MACE. Patients ...